Pluvicto Real-world Investigation in Survival in Metastatic CRPC | stella

Learn Find trials matched to me

Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy For Researchers Data Labs ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pluvicto Real-world Investigation in Survival in Metastatic CRPC | stella

Back to Prostatic Neoplasms, Castration-Resistant trials

Recruiting

Plain-English translation of NCT07697989 on ClinicalTrials.gov ↗ · Source last updated October 2026 · How we translate trials

Trial locations(1 site)

United States

Novartis, East Hanover, New Jersey

Key details

Sponsor

Novartis Pharmaceuticals

Enrollment target

~1,085 participants

Started

October 2026

Primary completion

January 2027

Age range

18 Years and older

Sex

Male only

Last updated on clinicaltrials.gov in October 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Novartis Pharmaceuticals

Novartis Pharmaceuticals

View full record on ClinicalTrials.gov

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.